A consensus on the diagnosis and treatment of acromegaly complications.
about
The risks of overlooking the diagnosis of secreting pituitary adenomasDiabetes in Patients With Acromegaly.Challenges in the diagnosis and management of acromegaly: a focus on comorbidities.Pegvisomant in acromegaly: an update.AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up.Use of Pegvisomant in acromegaly. An Italian Society of Endocrinology guidelineExpert consensus document: A consensus on the medical treatment of acromegaly.Health Outcomes in Acromegaly: Depression and Anxiety are Promising Targets for Improving Reduced Quality of Life.Growth hormone tumor histological subtypes predict response to surgical and medical therapy.What is the effect of peripheral muscle fatigue, pulmonary function, and body composition on functional exercise capacity in acromegalic patients?Acromegaly with cardiomyopathy, cardiac thrombus and hemorrhagic cerebral infarct: a case report of therapeutic dilemma with review of literature.Change in quality of life in patients with acromegaly after treatment with octreotide LAR: first application of AcroQoL in Korea.Medical management of functioning pituitary adenoma: an update.The association between biochemical control and cardiovascular risk factors in acromegaly.Soluble Klotho protein as a novel serum biomarker in patients with acromegaly.Prevalence of colonic polyp and its predictors in patients with acromegaly.Preconception counselling for women with acromegaly: More questions than answers.Communication practices and awareness of resources for acromegaly patients among endocrinologists.Pituitary adenomas in childhood and adolescence with a focus on intratumoral hemorrhage.Frequency of multiple endocrine neoplasia type 1 in a group of patients with pituitary adenoma: genetic study and familial screening.Safety and tolerability of pasireotide long-acting release in acromegaly-results from the acromegaly, open-label, multicenter, safety monitoring program for treating patients who have a need to receive medical therapy (ACCESS) studyLong-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study.Predictors of Quality of Life in Acromegaly: No Consensus on Biochemical ParametersOctreotide for acromegaly treatment: a reappraisal.Emerging drugs for acromegaly.Pituitary tumors and pregnancy: the interplay between a pathologic condition and a physiologic status.The role of colonoscopic screening in acromegaly revisited: review of current literature and practice guidelines.Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors.Treatment of acromegaly in the era of personalized and predictive medicine.Evidence of dysexecutive syndrome in patients with acromegaly.A multicenter, observational study of lanreotide depot/autogel (LAN) in patients with acromegaly in the United States: 2-year experience from the SODA registry.Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database.Management of aggressive growth hormone secreting pituitary adenomas.Current and future medical treatments for patients with acromegaly.The role of combination medical therapy in the treatment of acromegaly.Acromegalic osteopathy.Acromegaly: clinical features at diagnosis.Cardiovascular comorbidities in acromegaly: an update on their diagnosis and management.Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities.Usefulness of an ad hoc questionnaire (Acro-CQ) for the systematic assessment of acromegaly comorbidities at diagnosis and their management at follow-up.
P2860
Q28076665-3013F38C-88BE-4FC2-9C0C-104203615711Q30238646-88B53A70-DB50-4BBA-AB70-D483DD7EC118Q30249746-07BA9CD9-561E-435F-A47B-288132AFB5FFQ33725999-7850C521-0AEA-49FC-BBFF-A1C7F72F867EQ33895577-529F404B-CBDC-4FC4-AB9D-2156DAF3482AQ34277844-2B15463A-B515-442F-BD90-ED198B6E1CF6Q34406566-BC17505F-AA1B-4163-A5B6-B663D105C6A6Q34840936-75C05EF4-C1AD-4AFB-A264-7A9A06B66D94Q35091578-B516C10B-EB11-4B44-9889-DA3F5F50D494Q35398197-659A1C07-91B0-4711-AACE-9D489286A17FQ35428187-93A0C807-CFD0-4669-94F2-46D2A71158CBQ35740478-EE8B51B6-4EF4-4E3D-8A5C-904D44C5FD69Q35943493-64C72702-4F40-43B6-A2FF-CBCBADAFD770Q36303177-7399A0D0-31FA-4782-ABC3-5498407914D9Q36582313-B773F70E-08CA-40EA-B597-E1780A53B1FFQ37015567-6919324B-51F6-4BB1-A698-0B31497605D6Q37107351-09BB54B8-C29B-4E69-8C27-A83EFE503A64Q37515368-D2FA2348-3A65-45C0-A885-9606BADE6EC2Q37531036-C00748E7-DD56-42E6-A77D-19357B06B4F3Q37531060-CC0BAC85-8B73-4FC9-BDCB-4D3AC1B66EF9Q37578420-F275A691-0EF0-47D3-95FA-76BA239EB7CCQ37617510-7C007522-F887-4412-A104-C2775E3FB08BQ37678328-E42C8472-845F-4200-97D7-FEFE19217AD2Q38152458-40EB9207-D177-4CFE-8FEE-88E1DE9B9323Q38176659-4F4496DC-7DFB-4F48-A386-18AAC9827C33Q38185334-66F6CDF2-5554-49D2-AB4F-F1F8AB1F61CAQ38232848-1F4612D4-8005-499B-9696-436CA8B19A46Q38233686-31DEE05A-D818-40A6-8357-A4E252459C1FQ38340014-FFFED2F1-15C0-4408-A296-C8D3632450EEQ38371925-94596217-7019-495B-8E70-9485E5DCC6A5Q38373377-8C76D38A-146D-4CE1-A8AD-2CA0FB5922B1Q38667209-9008BC48-352F-4FC6-8C68-3B3CA6F34943Q38781620-EE67370F-771E-45FB-AE53-FE2E5CDE1951Q38847622-74DBE9D0-879C-47DC-A57B-D5C53DEF9B46Q38927318-A3B47D88-EFB8-483B-8021-0015D487E214Q38973343-A9EE8AA1-CBA1-4B49-A967-B356FE867343Q38998304-10E59E7F-589F-4FD3-98BF-5EBFF6523521Q39064562-43FDB9DB-658F-473B-BE36-DC16CC0BED5AQ39146196-9D27B5DF-A3DB-4040-B6FA-187FDF8F2D35Q39787849-33A5B3B8-2B1C-400F-8D67-82820B6CFE45
P2860
A consensus on the diagnosis and treatment of acromegaly complications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A consensus on the diagnosis and treatment of acromegaly complications.
@en
A consensus on the diagnosis and treatment of acromegaly complications.
@nl
type
label
A consensus on the diagnosis and treatment of acromegaly complications.
@en
A consensus on the diagnosis and treatment of acromegaly complications.
@nl
prefLabel
A consensus on the diagnosis and treatment of acromegaly complications.
@en
A consensus on the diagnosis and treatment of acromegaly complications.
@nl
P2093
P2860
P1433
P1476
A consensus on the diagnosis and treatment of acromegaly complications.
@en
P2093
A Giustina
A Klibanski
C J Strasburger
F F Casanueva
J A H Wass
M D Bronstein
S W Lamberts
P2860
P2888
P304
P356
10.1007/S11102-012-0420-X
P577
2013-09-01T00:00:00Z